Nous utilisons des cookies essentiels pour l'authentification et les préférences. Les cookies d'analyse ne sont chargés qu'avec votre consentement. En savoir plus
The French OTC & Self-Care Market Market Entry Guide for Foreign Suppliers of Branded and Private-Label Products OTC medicines · Food supplements · Consumer medical devices · Pharmacy dermocosmetics Market volume · Key players · Opportunities · Access requirements (EU / non-EU Europe / outside Europe) · Directory of importers and distribution partners Edition: October 2026 French
Table of Contents
1. Executive Summary......................................................................................................................................3
2. Market Definition and Scope.........................................................................................................................3
3. Market Volume and Trends........................................................................................................................... 4
3.1 Market size............................................................................................................................................4
3.2 Long-term development.........................................................................................................................4
3.3 Key trends.............................................................................................................................................. 4
4. Distribution Structure....................................................................................................................................5
4.1 Pharmacy channel................................................................................................................................. 5
4.2 Other channels......................................................................................................................................5
5. Major Market Players....................................................................................................................................5
5.1 Manufacturers and brand owners..........................................................................................................5
5.2 Wholesalers and pharmacy groups.......................................................................................................6
6. Market Opportunities for Foreign Suppliers.................................................................................................. 6
6.1 Branded products.................................................................................................................................. 6
6.2 Private label / No-name.........................................................................................................................6
6.3 Success factors.....................................................................................................................................7
7. Products and Product Groups with Good Sales Prospects...........................................................................7
8. Market Access Requirements....................................................................................................................... 8
8.1 Requirements applying to all suppliers..................................................................................................8
8.2 Suppliers from the EU / EEA..................................................................................................................8
8.3 Suppliers from non-EU Europe (e.g., Switzerland, United Kingdom, Turkey, Serbia, Ukraine).............9
8.4 Suppliers from outside Europe (e.g., USA, Asia, Latin America, Middle East).......................................9
8.5 Overview by origin.................................................................................................................................9
9. Market Entry Strategy and Practical Recommendations.............................................................................10
10. Directory of Importers and Distribution Partners.......................................................................................10
10.1 Pharmaceutical Full-Line Wholesalers (Grossistes-Répartiteurs)......................................................10
10.2 Pharmacy Groups and Central Purchasing (CAP/SRA) – incl. Own-Brand Programmes..................12
10.3 OTC / Pharma Importers, Exploitants and In-Licensing Partners......................................................14
10.4 Supermarket Central Purchasing and Discounters............................................................................16
10.5 Organic and Natural Health Retailers................................................................................................17
10.6 Online Pharmacies and Health & Beauty E-Retailers........................................................................18
10.7 FMCG and Full-Range Non-Food Importers......................................................................................19
10.8 Useful Institutions and Trade Bodies.................................................................................................19
11. How to Approach French Partners............................................................................................................ 19
12. Sources and Methodology........................................................................................................................20
1. Executive Summary
France is one of Europe's largest self-care markets, but also one of its most regulated. Non-prescription medicines may only be sold in pharmacies (including the online shops of pharmacies), and almost the entire pharmacy self-care segment – OTC medicines, food supplements and consumer medical devices – is sold through roughly 20,000 community pharmacies supplied by a handful of full-line wholesalers and organised in purchasing groups. In 2025 the pharmacy "first-line" market (produits de premier recours: non-prescription medicines, food supplements and consumer medical devices, measured at consumer prices) reached €4.74 bn (+2 %). Growth is driven almost entirely by food supplements (€1.65 bn, +5.1 %), while OTC medicines are flat (+0.2 %) and consumer medical devices grow slowly (€0.90 bn, +0.9 %). Across all channels the food-supplement market passed €3 bn for the first time in 2025, with pharmacies accounting for about 55 % of sales. Key conclusions for foreign suppliers: • Medicines (OTC drugs) require a marketing authorisation and a French or EU-based pharmaceutical "exploitant". For most foreign manufacturers the realistic routes are out-licensing or distribution agreements with French OTC laboratories (e.g., Cooper, Mayoly, Genevrier, Gilbert, Perrigo France) or the decentralised/mutual-recognition procedure with a local partner. • Food supplements, medical devices and dermocosmetics offer the fastest entry: no marketing authorisation, but French declaration/notification, French labelling and EU-compliant formulations are mandatory. • Private label is a real opportunity: pharmacy groups (Giphar, Lafayette/Hygie31, Pharmabest, Aprium) and wholesalers are expanding own-brand ranges, while supermarkets and discounters source private-label supplements and hygiene products by tender. • Best prospects: sleep/stress and mood supplements, immunity and vitality, digestion/probiotics, women's health (menopause, fertility), joint health, natural and organic formulations, saline/ENT and dry-eye medical devices, dermocosmetics for sensitive skin and sun care. • Market access differs sharply by origin: EU/EEA suppliers benefit from free movement and mutual recognition; suppliers from non-EU Europe (Switzerland, UK, Turkey, Western Balkans, Ukraine) and from outside Europe need an EU-based responsible party (importer, EU Responsible Person, Authorised Representative, Qualified Person release) and must clear customs and border controls.
Vérifiez le marché, les secteurs et la date de révision avant d'acheter.
English